EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieVergleichsstudieOpen Access · CC BY 4.0

Fasting vs Nonfasting, Dose-adjusted Levothyroxine Ingestion in Hypothyroidism: A Randomized Clinical Trial

Jeresa I A Willems iD, Daan J L van Twist iD, Floris Helmich, Thijs Sluiter, Marco Medici iD, Robin P Peeters iD, Roderick F A Tummers-de Lind van Wijngaarden

The Journal of Clinical Endocrinology & Metabolism · 17.03.2026 · 111 (4) · 938-944

DOI: 10.1210/clinem/dgaf686 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 23.12.2025. Verfasst von Jeresa I A Willems und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Zuyd Thyroid Center, Zuyderland Medical Center, 6162 BG Sittard-Geleen, The Netherlands. Hauptthemen laut MEDLINE: Thyroxine, Fasting, Hypothyroidism, Hormone Replacement Therapy. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Levothyroxine (LT4) is recommended for intake in a fasting state to optimize absorption. However, fasting intake is often burdensome and may reduce adherence. In a previous questionnaire study, we observed a strong patient preference for taking LT4 with breakfast. Therefore, we conducted a randomized controlled trial to evaluate whether nonfasting LT4 intake—accompanied by a 15% dose increase—could maintain TSH stability compared to fasting LT4 intake.

Methods

Adults with well-controlled hypothyroidism were randomized to fasting or dose-adjusted, breakfast LT4 intake. TSH, free T4, and total T3 were measured every 6 weeks, followed by LT4 dose adjustment if needed. The primary outcome was TSH stability, defined as 2 consecutive values within the reference range and a maximum ±1 mIU/L change from baseline. Patients were followed until TSH stability was reached, with a maximum of 24 weeks. After the initial study period, patients in the fasting group were invited to cross over to nonfasting intake, with similar follow-up.

Results

Eighty-eight patients (80.7% female, median age 62y [interquartile range: 49-69]) were randomized to fasting (n = 43) or breakfast intake (n = 45). TSH stability was comparable between groups: 74.4% [95% confidence interval (CI): 61.0-88.0%] in the fasting vs 73.3% (95%CI: 60.0-87.0%) in the breakfast group (P = not significant). Similar findings were observed in the crossover group. The breakfast group reported greater improvement in self-reported well-being (33.3% vs 16.3%, P = .07) and a stronger preference for nonfasting intake (76.2% vs 44.2%, P < .001). By the end of the study, 88.9% chose to continue nonfasting intake.

Conclusion

LT4 ingestion with breakfast with a 15% dose increase maintained TSH stability and improved patient well-being. Given the strong patient preference, this patient-centered approach may offer a viable alternative to fasting administration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThyroxineFastingHypothyroidismHormone Replacement TherapyHumansFemaleMaleMiddle AgedAgedThyrotropinBreakfastCross-Over StudiesFollow-Up StudiesDose-Response Relationship, Drug

Stichwörter der Autor:innen

breakfastfasting ingestionhypothyroidismlevothyroxine

Substanzen

ThyroxineThyrotropin

Autor:innen und Institutionen

  • Department of Internal Medicine, Zuyd Thyroid Center, Zuyderland Medical Center, 6162 BG Sittard-Geleen, The Netherlands.
  • Department of Clinical Chemistry and Hematology, Zuyderland Medical Center, 6162 BG Sittard-Geleen, The Netherlands.
  • Academic Center for Thyroid Diseases, Department of Internal Medicine, Erasmus Medical Center, 3015 GD Rotterdam, The Netherlands.

ORCID-Profile: Jeresa I A Willems, Daan J L van Twist, Marco Medici, Robin P Peeters

Zitieren

APA

Willems, J. I. A., van Twist, D. J. L., Helmich, F., Sluiter, T., Medici, M., Peeters, R. P., & Tummers-de Lind van Wijngaarden, R. F. A. (2026). Fasting vs Nonfasting, Dose-adjusted Levothyroxine Ingestion in Hypothyroidism: A Randomized Clinical Trial. The Journal of Clinical Endocrinology & Metabolism, 111(4), 938-944. https://doi.org/10.1210/clinem/dgaf686

Vancouver

Willems JIA, van Twist DJL, Helmich F, Sluiter T, Medici M, Peeters RP, et al. Fasting vs Nonfasting, Dose-adjusted Levothyroxine Ingestion in Hypothyroidism: A Randomized Clinical Trial. The Journal of Clinical Endocrinology & Metabolism. 2026;111(4):938-944. doi:10.1210/clinem/dgaf686

BibTeX
@article{Willems2026,
  author = {Willems, Jeresa I A and van Twist, Daan J L and Helmich, Floris and Sluiter, Thijs and Medici, Marco and Peeters, Robin P and Tummers-de Lind van Wijngaarden, Roderick F A},
  title = {Fasting vs Nonfasting, Dose-adjusted Levothyroxine Ingestion in Hypothyroidism: A Randomized Clinical Trial},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2026},
  volume = {111},
  number = {4},
  pages = {938--944},
  doi = {10.1210/clinem/dgaf686}
}
Kostenlos starten →